Answers are grounded in this paper and cite their sources.
Endovascular treatment is the first-line therapy for most intracranial aneurysms; however, recanalisation remains a major limitation. Developments in bioengineering and material science have led to a novel generation of coil technologies for aneurysm embolisation that address clinical challenges of aneurysm recurrence. This review presents an overview of modified surface coil technologies and summarises the state of the art regarding their efficacy and limitations based on experimental and clinical results. We also present potential perspectives to develop biologically optimised devices.
No takes yet. Share an insight, caveat, or question.
Szatmáry et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: